Prudential Financial Inc. Cuts Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Prudential Financial Inc. lowered its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 16.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 25,336 shares of the biopharmaceutical company’s stock after selling 5,157 shares during the quarter. Prudential Financial Inc.’s holdings in Cytokinetics were worth $1,192,000 […]